![Brenda Reynolds](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brenda Reynolds
Director/Board Member at iQur Ltd.
Network origin in Brenda Reynolds first degree
Entity | Entity type | Industry | |
---|---|---|---|
PowderMed Ltd.
![]() PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom.
7
| Extinct | Pharmaceuticals: Major | 7 |
iQur Ltd.
![]() iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom.
4
| Holding Company | Biotechnology | 4 |
Pleco Therapeutics BV
![]() Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Adiga Life Sciences, Inc.
![]() Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada.
3
| Private Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brenda Reynolds via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
The University of Southampton | College/University | Undergraduate Degree Corporate Officer/Principal | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Founder | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal | |
CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Ervaxx Ltd.
![]() Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Pharmaceuticals: Major | Director/Board Member | |
Alchemab Therapeutics Ltd.
![]() Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Director/Board Member | |
Cybele Therapeutics Ltd.
![]() Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Cybele Therapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 23, 2019 and is headquartered in Reading, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Mestag Therapeutics Ltd.
![]() Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
BicycleTx Ltd.
![]() BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | Miscellaneous Commercial Services | Director/Board Member | |
The Francis Crick Institute Ltd.
![]() The Francis Crick Institute Ltd. Medical/Nursing ServicesHealth Services The Francis Crick Institute Ltd. operates as a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. The firms works helps to understand why disease develops and to find new ways to treat, diagnose, and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
SV Health Investors LLP
![]() SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
St. Paul's Girls' School | College/University | Director/Board Member | |
Sitryx Therapeutics Ltd.
![]() Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member | |
Pulmocide Ltd.
![]() Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Zarodex Therapeutics Ltd.
![]() Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
University of Warwick | College/University | Masters Business Admin | |
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
SV Health Investors UK Ltd.
![]() SV Health Investors UK Ltd. Financial ConglomeratesFinance Part of SV Health Investors LLP, SV Health Investors UK Ltd. is a company that provides investment services. The company is based in London, UK and was founded in 2004. | Financial Conglomerates | Director/Board Member | |
RespiVert Ltd.
![]() RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Medical Distributors | Director/Board Member | |
Adaptate Biotherapeutics Ltd.
![]() Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Telectronics Pacing Systems, Inc.
![]() Telectronics Pacing Systems, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Telectronics Pacing Systems, Inc. is a company that manufactures pacemakers. The company is based in Philadelphia, PA. | Medical Specialties | Corporate Officer/Principal | |
Scorpion Therapeutics, Inc.
![]() Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
LeukoSite, Inc.
![]() LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
MedNova Ltd.
![]() MedNova Ltd. Medical SpecialtiesHealth Technology MedNova Ltd. manufactures medical devices. The company specializes in the development of minimally-invasive vascular products for the protection and repair of the heart, brain and blood vessels. It was founded in 1996 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member | |
SV Health Managers LLP
![]() SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | Investment Managers | Chief Executive Officer | |
SV Health Investors LLC
![]() SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Monitor Co. Group LP | Corporate Officer/Principal | ||
Convergence Pharmaceuticals Ltd.
![]() Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Autifony Therapeutics Ltd.
![]() Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
LUX Assure Ltd.
![]() LUX Assure Ltd. Chemicals: Major DiversifiedProcess Industries LUX Assure Ltd. provides technology solutions to monitor difficult-to-detect chemicals used by the oil industry. Its offers CoMic a technology that enables optimization of chemicals used for corrosion protection and OMMICA a testing kit for analyzing the concentration of the thermodynamic hydrate inhibitors methanol and monoethylene glycol in water, crude oil, and condensate. The company was founded by Patrick Hickey on May 30, 2001 and is headquartered in Edinburgh, the United Kingdom. | Chemicals: Major Diversified | Chairman | |
Kesios Therapeutics Ltd.
![]() Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
University of London | College/University | Graduate Degree | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
NIOX GROUP PLC | Medical/Nursing Services | Founder | |
Sensyne Health Holdings Ltd.
![]() Sensyne Health Holdings Ltd. Electronic Production EquipmentElectronic Technology Sensyne Health Holdings Ltd. provides wireless charging technology. It focuses on developing wireless energy devices and wireless sensor networks. The company was founded by Elspeth Drayson, Paul R. Drayson and Manuel Pinuela in April 2014 and is headquartered in London, the United Kingodm. | Electronic Production Equipment | Director/Board Member | |
SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Middlesex University | College/University | Doctorate Degree | |
Zeneus Pharma Ltd.
![]() Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Director/Board Member |
Statistics
International
United Kingdom | 37 |
United States | 13 |
Ireland | 2 |
Germany | 2 |
Sectoral
Health Technology | 25 |
Consumer Services | 8 |
Commercial Services | 8 |
Finance | 6 |
Health Services | 3 |
Operational
Director/Board Member | 106 |
Corporate Officer/Principal | 21 |
Chairman | 20 |
Chief Executive Officer | 11 |
Founder | 8 |
Most connected contacts
Insiders | |
---|---|
Timothy Haines | 36 |
Kate Bingham | 31 |
Mark P. Carthy | 23 |
Jerry Christopher Benjamin | 15 |
Rolf Stahel | 13 |
Adam Christie | 11 |
Charles Swingland | 10 |
David Campbell | 9 |
John Tite | 6 |
William Rosenberg | 5 |
Debra Ainge | 5 |
Ivo Timmermans | 4 |
Callum Meikle | 2 |
David Gannaway | 1 |
Michael Underwood | 1 |
- Stock Market
- Insiders
- Brenda Reynolds
- Company connections